Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
474 Leser
Artikel bewerten:
(2)

Emergence Global Enterprises Inc. Announces Acquisition of Edge Nutrition (Canada) Inc.

Finanznachrichten News

WINDSOR, ON / ACCESSWIRE / March 10, 2021 / Emergence Global Enterprises Inc. ("Emergence Global" or the "Company") (CSE:EMRG) (OTCQB:ELOAF), an acquirer, creator, and builder of reputable natural health consumer foods, products, and brands, is pleased to announce that it has completed its acquisition of all of the issued and outstanding capital shares in the capital of Edge Nutrition (Canada) Inc. ("Edge") (the "Transaction"), a traditional and e-commerce company of branded all-natural foods, sports and nutrition specialty supplements targeting healthy & active lifestyles, keto, paleo, vegan and fasting conscious consumers. Edge Nutrition ® currently owns and operates a retail location in Windsor, Ontario, along with its e-commerce platform on www.edgenutrition.com. Edge also owns and operates retail brands under BMF Hardcore ® and American Sports Nutrition®. The acquisition was completed pursuant to a share purchase agreement (the "Purchase Agreement"), dated March 10, 2021. Under the terms of the Purchase Agreement, the sole shareholder of Edge (the "Vendor") received aggregate consideration of 525,000 common shares in the capital of the Company ("Common Shares") issued to the Vendor at the closing time. The Price per Share at the close of the market on the day prior was $.85.

According to Joe Byrne, President & CEO of Emergence Global Enterprises, "The acquisition of Edge Nutrition (Canada) Inc. provides a strategic addition to our long-term vision that aligns with our strong brands and businesses. Due to COVID-19, Emergence Global-related brands have seen significant activity as more people seek to improve their health using organic natural foods and nutritional supplements. We are also excited to add two great active lifestyle brands in BMF Hardcore ® and American Sports Nutrition ®, strengthening our consumer brand lineup and enabling us to target specific segments within the active lifestyle category. Driven by our mission to help others make a difference in their health, we continue to execute our plan in becoming a global vertically integrated player in the organic, natural food, and supplement marketplace.

Additional information about the Company can be found on SEDAR under the Issuer Profile of "Emergence Global Enterprises Inc." or on OTC MARKETS.

About the Company
Emergence Global Enterprises Inc. ("Emergence") is an acquirer, creator, and builder of reputable natural health consumer foods, products, and brands. Following the acquisition of Nubreed Nutrition, Inc., Emergence has become a North American developer and distributor of branded sports and nutrition specialty supplements. The Company is currently considering several development projects.

For further information on the Company, contact: Joseph Byrne, President & Chief Executive Officer and a Director at phone: 519-257-0460 or by email at: joe@emergenceglobalinc.com.

Cautionary Statement Regarding Forward-Looking Information

Forward-Looking Statements
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to: closing and the terms and conditions of the proposed transaction; the business and operations of the Company after closing the proposed transaction. Forward looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward- looking statements, whether as a result of new information, future events or otherwise, except as required by law. There can be no assurance that the proposed transaction will occur or that the anticipated financial, economic or strategic benefits will be realized.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) or OTC Markets accepts responsibility for the adequacy or accuracy of this press release.

Related Images

SOURCE: Emergence Global Enterprises Inc.



View source version on accesswire.com:
https://www.accesswire.com/634812/Emergence-Global-Enterprises-Inc-Announces-Acquisition-of-Edge-Nutrition-Canada-Inc

© 2021 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.